Jan Willem Hinnen

Jan Willem Hinnen

Auto-generated profile, based on publicly available information

Jan Willem Hinnen

Department of Vascular Surgery, Jeroen Bosch Ziekenhuis, ’s-Hertogenbosch, GZ, The Netherlands

Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
14 October 2020 in Journal of Clinical Medicine
Verified
Journal Article
Open access
PDF file
BLBernard Leenstra
Bernard Leenstra
RKRobert de Kleijn
Robert de Kleijn
GKGeoffrey Kuppens
Geoffrey Kuppens
BVBart Arnoldus Nicolaas Verhoeven
Bart Arnoldus Nicolaas Verhoeven
JHJan Willem Hinnen
Jan Willem Hinnen
Gert Jan de BorstGert Jan de Borst
Gert Jan de Borst
Currently, transcutaneous oxygen tension measurement (TCpO2) is the most favorable non-invasive test for diabetic foot ulcer (DFU) healing prognosis. Photo-optical TCpO2 is novel, less time-consuming and more practical in use compared to regular electro-chemical TCpO2. We prospectively investigated the clinical value of photo-optical TCpO2 to predict DFU healing. Patients with suspected DFU undergoing conservative treatment underwent an ankle pressure, toe-pressure and photo-optical TCpO2 test. The primary endpoint was DFU wound healing at 12 months. Based on their clinical outcome, patients were divided into a DFU healing and DFU non-healing group. Healing was defined as fully healed ulcers and non-healing as ulcers that deteriorated under conservative treatment or that required surgical amputation. Differences between groups were analyzed and an optimal TCpO2 cut-off value was determined. In total, 103 patients were included, of which 68 patients (66%) were classified as DFU healing. The remaining 35 patients (34%) had deteriorated ulcers, of which 29 (83%) eventually required surgical amputation. An optimal TCpO2 cut-off value of 43 mmHg provided a sensitivity, specificity and odds ratio of 0.78, 0.56 and 4.4, respectively. Photo-optical TCpO2 is an adequate alternative tool to validate the vascular status of the lower extremity indicating healing prognosis in patients with DFU. Therefore, we recommend that photo-optical TCpO2 can be safely coapplied in clinical practice to assist in DFU treatment strategy.

1 January 2015 in Acta Chirurgica Belgica
Verified
Journal Article
Closed access
JHJ. W. Hinnen
J. W. Hinnen
MKM. A. Konickx
M. A. Konickx
RMR. Meerwaldt
R. Meerwaldt
JKJ. L. P. Kolkert
J. L. P. Kolkert
JPJ. van der Palen
J. van der Palen
RGR.H. Geelkerken
R.H. Geelkerken
Background: To evaluate the long-term outcome after aortoiliac kissing stent placement and to analyze variables, which potentially influence the outcome of endovascular reconstruction of the aortic bifurcation. Methods : All patients treated with aortoiliac kissing stents at our institution between April 1995 and August 2011 were retrospectively identified from a prospective single-center database. Data regarding patient characteristics (age, gender, smoking, cardio-and cerebrovascular risk factors, hyperlipidaemia, diabetes mellitus and use of antihypertensive medication), symptoms, pre-interventional examination and imaging, procedural details and follow-up were retrieved. Patency rates were calculated with Kaplan-Meier analysis. Factors affecting the patency were determined with Cox uni-and multivariate analysis. Results : A total of 215 patients (63% men, mean age 61 ± 10 years) were included. The median follow-up period was 31 (IQR 47.1) months. Primary, primary assisted, and secondary patency rates were 97%, 97%, and 99%, respectively, at one month; 92%, 95% and 94% at four months; 75%, 86%, and 91% at two years; 70%, 81%, and 91% at 5 years; and 67%, 81%, and 91% at ten years. Younger age and previous aortoiliac treatment were predictors for reduced primary and primary assisted patency. Smoking, previous aortoiliac intervention, TASC C and D lesions were predictors for reduced secondary patency. Conclusion : Reconstruction of the aortoiliac bifurcation with kissing stents is feasible, safe and effective in all types of lesions with satisfying long term patencies. TASC C and D lesions are associated with a higher occlusion rate. Younger age and previous aortoiliac interventions are predictors for reduced primary and primary assisted patency.

7 June 2021 in Expert Review of Medical Devices
Verified
Journal Article
Closed access
MNMichael J. Nugteren
Michael J. Nugteren
FCFabio S. Catarinella
Fabio S. Catarinella
OKOlivier H.J. Koning
Olivier H.J. Koning
JHJan-Willem Hinnen
Jan-Willem Hinnen
Introduction: Peripheral arterial disease (PAD) is an occlusive vascular disease of the lower extremities with increasing incidence and prevalence numbers and therefore rising health care costs. Mobile applications have great potential to improve health system efficiency and can assist in overcoming the increasing health care costs. In this review all available mobile applications developed for PAD are summarized and a new innovative application is introduced. Areas covered: Available applications for PAD are scarce and currently aim at prevention, teleconsultation and telemonitoring via questionnaires and activity tracking. Integration in the daily workflow of the physician is an overlooked aspect of these applications. JBZetje is an innovative mobile application that provides remote care, information services and self-service tools, and enables connection with the electronic health record (EHR). Expert opinion: Connection of the application with the EHR generates a complete overview of a patient’s current health status. This will reinforce the tendency toward personalized medicine and will probably lead to reduced health care costs and increase the quality of care. Future feasibility studies should answer the question whether the use of mobile applications is feasible in the PAD population.

26 September 2018 in Cardiovascular Intervention and Therapeutics
Verified
Journal Article
Closed access
PDF file
HMHanneke P. F. X. Moonen
Hanneke P. F. X. Moonen
OKOlivier H. J. Koning
Olivier H. J. Koning
RHRonald F. van Den Haak
Ronald F. van Den Haak
BVBart A. N. Verhoeven
Bart A. N. Verhoeven
JHJan Willem Hinnen
Jan Willem Hinnen

21 May 2021 in Journal of Scientific Innovation in Medicine
Verified
Journal Article
Open access
PDF file
MGMark Greveling
Mark Greveling
MBMaaike De Bondt
Maaike De Bondt
FWFeike Weijzen
Feike Weijzen
RGRobert Geelkerken
Robert Geelkerken
MVMark Vlutters
Mark Vlutters
JHJanwillem Hinnen
Janwillem Hinnen